Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

被引:7
|
作者
Zhang, Rongli [1 ,2 ,3 ]
He, Yi [1 ,2 ,3 ]
Yang, Donglin [1 ,2 ,3 ]
Wang, Ying [2 ,4 ]
Feng, Sizhou [1 ,2 ,3 ]
Wang, Jianxiang [2 ,5 ]
Han, Ming-Zhe [1 ,2 ,3 ]
机构
[1] CAMS, Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China
[2] CAMS, Hosp Blood Dis, Tianjin, Peoples R China
[3] PUMC, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Leukemia Ctr, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China
关键词
donor-derived CD19 CAR-T cell therapy; allogenic stem cell transplantation; B cell acute lymphoblastic leukemia; relapse;
D O I
10.1182/blood-2018-99-114950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2179
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [31] CAR-T Cell Therapy With CRISPR/CAS9 Engineering for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia, With Universal Dual Target CD19/CD22
    Baptista, Gabriel
    Carvalho, Julia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S529 - S529
  • [32] Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant
    Zhang, Cheng
    Wang, Xiao-Qi
    Zhang, Rong-Li
    Liu, Fang
    Wang, Yi
    Yan, Zhi-Ling
    Song, Yong-Ping
    Yang, Ting
    Li, Ping
    Wang, Zhen
    Ma, Ying-Ying
    Gao, Lei
    Liu, Yao
    Gao, Li
    Kong, Pei-Yan
    Liu, Jun
    Tan, Xu
    Zhong, Jiang F.
    Chen, Yu-Qing
    Liang, Ai-Bin
    Ren, Jin-Hua
    Li, Zhen-Yu
    Cao, Jiang
    Gao, Quan-Li
    Zhou, Jian
    Gao, Ying
    Zhang, Ding
    Fan, Fang-Yi
    Han, Ming-Zhe
    Gale, Robert Peter
    Zhang, Xi
    LEUKEMIA, 2021, 35 (06) : 1563 - 1570
  • [33] Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant
    Cheng Zhang
    Xiao-Qi Wang
    Rong-Li Zhang
    Fang Liu
    Yi Wang
    Zhi-Ling Yan
    Yong-Ping Song
    Ting Yang
    Ping Li
    Zhen Wang
    Ying-Ying Ma
    Lei Gao
    Yao Liu
    Li Gao
    Pei-Yan Kong
    Jun Liu
    Xu Tan
    Jiang F. Zhong
    Yu-Qing Chen
    Ai-Bin Liang
    Jin-Hua Ren
    Zhen-Yu Li
    Jiang Cao
    Quan-Li Gao
    Jian Zhou
    Ying Gao
    Ding Zhang
    Fang-Yi Fan
    Ming-Zhe Han
    Robert Peter Gale
    Xi Zhang
    Leukemia, 2021, 35 : 1563 - 1570
  • [34] Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation
    Lu, Wenyi
    Lyu, Hairong
    Xiao, Xia
    Bai, Xue
    Zhang, Meng
    Wang, Jiaxi
    Pu, Yedi
    Meng, Juanxia
    Zhang, Xiaomei
    Zhu, Haibo
    Yuan, Ting
    Wang, Bing
    Jin, Xin
    Cao, Xinping
    Wang, Zhao
    Xie, Tianle
    Meng, Haotian
    Stepanov, Alexey V.
    Gabibov, Alexander G.
    An, Yuxin
    Sun, Rui
    Zhang, Yu
    Maschan, Mikhail A.
    Zhu, Zunmin
    Zhang, Hongkai
    Zhao, Mingfeng
    LEUKEMIA, 2024, 38 (06) : 1419 - 1422
  • [35] Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Magnani, Chiara F.
    Gaipa, Giuseppe
    Belotti, Daniela
    Matera, Giada
    Tettamanti, Sarah
    Cabiati, Benedetta
    Buracchi, Chiara
    Fazio, Grazia
    Zaninelli, Silvia
    Rigamonti, Silvia
    Cesana, Stefania
    Colombo, Valentina
    Cazzaniga, Giovanni
    Rovelli, Attilio
    Balduzzi, Adriana
    Napolitano, Sara
    Benedicenti, Fabrizio
    Montini, Eugenio
    Borleri, Gian Maria
    Ferrari, Silvia
    Gritti, Giuseppe
    Lussana, Federico
    Introna, Martino
    Rambaldi, Alessandro
    Dastoli, Giuseppe
    Biondi, Andrea
    BLOOD, 2019, 134
  • [36] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2020, 136
  • [37] Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation
    Cheng Zhang
    Xiaoqi Wang
    Hai Yi
    Yi Wang
    Zhiling Yan
    Jian Zhou
    Ting Yang
    Aibin Liang
    Zhen Wang
    Yingying Ma
    Qin Wen
    Lei Gao
    Li Gao
    Peiyan Kong
    Xu Tan
    Erlie Jiang
    Xi Zhang
    Journal of Hematology & Oncology, 17 (1)
  • [38] Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
    Dai, Hanren
    Wu, Zhiqiang
    Jia, Hejin
    Tong, Chuan
    Guo, Yelei
    Ti, Dongdong
    Han, Xiao
    Liu, Yang
    Zhang, Wenying
    Wang, Chunmeng
    Zhang, Yajing
    Chen, Meixia
    Yang, Qingming
    Wang, Yao
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [39] CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
    Hu, Yongxian
    Zhou, Yali
    Zhang, Mingming
    Ge, Wengang
    Li, Yi
    Yang, Li
    Wei, Guoqing
    Han, Lu
    Wang, Hao
    Yu, Shuhui
    Chen, Yi
    Wang, Yanbin
    He, Xiaohong
    Zhang, Xingwang
    Gao, Ming
    Yang, Jingjing
    Li, Xiuju
    Ren, Jiangtao
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2764 - 2772
  • [40] Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant
    Cao, Xing-yu
    Zhang, Jian-ping
    Zhao, Yan-li
    Xiong, Min
    Zhou, Jia-rui
    Lu, Yue
    Sun, Rui-juan
    Wei, Zhi-jie
    Liu, De-yan
    Zhang, Xian
    Yang, Jun-fang
    Lu, Peihua
    FRONTIERS IN IMMUNOLOGY, 2023, 14